CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Aiming to leverage the knowledge of GSK's Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocata...Show all
Company (Alive / Active)
Phone: (+44017) 073-561-3044
Broadwater Road
BioPark Hertfordshire
AL7 3AX
United Kingdom
| Total Funding | Date of Last Funding | |
|---|---|---|
| Novacta Biosystems | $7.7M | Jul 6, 2009 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Company | Status | Description | Investors |
|---|---|---|---|
| La Jolla, California, United States | Acquired | Sequana provides research and development for gene discovery, characterization, and identification for drug discovery. | Login to see details |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Formulations for infusion of type b lantibiotics | Aug 09, 2011 | Nov 24, 2015 | Patent |
| Actagardine derivatives, and pharmaceutical use thereof | Feb 01, 2011 | Apr 14, 2015 | Patent |
| Lantibiotic biosynthetic gene clusters from | Dec 04, 2012 | Jul 08, 2014 | Patent |
| Compounds | May 21, 2012 | Jun 03, 2014 | Patent |
| Use of type-b lantibiotic-based compounds having antimicrobial activity | Jan 21, 2009 | Nov 05, 2013 | Patent |
